Kings Path Partners LLC Ligand Pharmaceuticals Inc Transaction History
Kings Path Partners LLC
- $204 Billion
- Q1 2025
A detailed history of Kings Path Partners LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Kings Path Partners LLC holds 5,065 shares of LGND stock, worth $539,878. This represents 0.26% of its overall portfolio holdings.
Number of Shares
5,065
Previous 8,260
38.68%
Holding current value
$539,878
Previous $885 Million
39.83%
% of portfolio
0.26%
Previous 0.38%
Shares
3 transactions
Others Institutions Holding LGND
# of Institutions
276Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$306 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$222 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$108 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$94.3 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$79.3 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.8B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...